(Q43901283)

27 November 2017

title

Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer (English)

1 reference

27 November 2017

7

Herbert Rübben

1 reference

27 November 2017

Tibor Szarvas

1

1 reference

27 November 2017

Tobias Jäger

2

1 reference

27 November 2017

Markus Becker

3

1 reference

27 November 2017

Stephan Tschirdewahn

4

1 reference

27 November 2017

Christian Niedworok

5

1 reference

27 November 2017

Ilona Kovalszky

6

1 reference

27 November 2017

Süleyman Ergün

8

1 reference

27 November 2017

Frank vom Dorp

9

1 reference

27 November 2017

publication date

21 January 2011

1 reference

Pathology Oncology Research

27 November 2017

published in

1 reference

27 November 2017

volume

17

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

325-332

1 reference

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

What do we mean by validating a prognostic model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

External validation is necessary in prediction research: a clinical example

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9320-4

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

21 January 2018

1 reference

12 December 2020

Expression of metalloproteinase genes in human prostate cancer

1 reference

12 December 2020

MMP-7 overexpression is an independent prognostic marker in gastric cancer

1 reference

12 December 2020

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

1 reference

12 December 2020

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

1 reference

12 December 2020

Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer

1 reference

12 December 2020

Impact of Blood Sampling on the Circulating Matrix Metalloproteinases 1, 2, 3, 7, 8, and 9

1 reference

12 December 2020

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

1 reference

12 December 2020

Matrix metalloproteinases generate angiostatin: effects on neovascularization

1 reference

12 December 2020

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

1 reference

12 December 2020

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

12 December 2020

Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy

1 reference

12 December 2020

[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder]

1 reference

12 December 2020

10.1007/S12253-010-9320-4

Identifiers

DOI

1 reference

27 November 2017

1 reference